Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. - Hemmi,H.; Kaisho,T.; Takeuchi,O.; Sato,S.; Sanjo,H.; Hoshino,K.; Horiuchi,T.; Tomizawa,H.; Takeda,K.; Akira,S. (Nat Immunol, 2002)